Insider Transactions in Q1 2023 at Comera Life Sciences Holdings, Inc. (CMRA)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 04
2023
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
743,243
+20.52%
|
$743,243
$1.23 P/Share
|
Jan 04
2023
|
Kirsten Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+37.84%
|
$13,513
$1.23 P/Share
|
Jan 04
2023
|
Edward Aloysius Sullivan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,979
+35.83%
|
$10,979
$1.23 P/Share
|
Jan 04
2023
|
Stuart A Randle Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,783
+44.3%
|
$33,783
$1.23 P/Share
|
Jan 04
2023
|
James Sherblom Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,081
+15.2%
|
$81,081
$1.23 P/Share
|
Jan 04
2023
|
Barbara K Finck Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,756
+22.68%
|
$6,756
$1.23 P/Share
|
Jan 04
2023
|
Sirshendu Roopom Banerjee Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,270
+41.18%
|
$20,270
$1.23 P/Share
|
Jan 04
2023
|
David Soane > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
202,701
+29.48%
|
$202,701
$1.23 P/Share
|